5 Stable Stocks For The Ideal Dividend PortfolioSeeking AlphaThe company's product portfolio covers drugs that deal with everything from hypertension, to schizophrenia, to diabetes, to cancer, and even to organ transplant rejection. With an increas…
UCLA seeking Wounded Warriors with severe facial injuries for clinical trialExaminer.comThe patient must agree to follow a drug schedule to prevent transplant rejection and attend all appointments at the transplant center. Patients who meet the criteri…
TopNews United States2nd Heart Transplant Rejection Claims Teenager's LifeTopNews United StatesHe keeps questioning to God that why they have taken his child away. Shaun's mother Sally Devers said that her whole world has broken, but she would …
abc7.comUCLA Launches First Face Transplantation Program In Western USMarketWatch (press release)The patient must agree to follow a drug schedule to prevent transplant rejection and attend all appointments at the transplant center. Dr. Gerald Lipshutz,…
HPQ, ALXN, PPL, P, RAI Had Unusual VolumeFyxnewsAlexion Pharmaceuticals, Inc is engaged in the discovery, development and delivery of biologic therapeutic products and life-threatening disease states, including hematologic and neurologic diseases, tran…
Lupus flare diagnostic to be developed under LabCorp, XDx partnershipMedCity NewsThe Brisbane, California company develops tests for monitoring transplant rejection as well as diagnostics for autoimmune diseases. XDx has a proprietary database of lupus…
FOX News RadioHOUSECALL FOR HEALTH: SKIN CELLS REPAIR HEARTFOX News Radio… where they successfully integrated with the existing tissue. Scientists say once the process is perfected, it could help eliminate the painful process of transplant rejection….
XDx and LabCorp Enter Into Collaboration and License Agreement …EON: Enhanced Online News (press release)… tests for the monitoring of transplant rejection and autoimmune diseases. … of acute cellular rejection for post-cardiac transplant patient…
XDx and LabCorp Enter Into Collaboration and License Agreement to Develop …MarketWatch (press release)XDx, Inc., based in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of non-inva…
Stems Cells May Lower Infection Risk in Transplant RecipientsRenal and Urology NewsThe use of mesenchymal stem cells derived from bone marrow instead of antibody induction may result in a lower incidence of acute rejection in adults receiving related-d…